Finance

Lists
Why is ARTV up 3,09%?
Dive Deeper
ARTV:NASDAQ
Artiva Biotherapeutics Inc
US$7,01
+3,09%
(+0,21) 1D
9 ຕ.ລ., 13 ໂມງ 17 ນາທີ 55 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARTV...
Open
US$6,84
High
US$7,14
Low
US$6,77
Mkt. cap
342,72 ລ້ານ
Avg. vol.
454,25 ພັນ
Volume
95,99 ພັນ
52-wk high
US$14,53
52-wk low
US$2,71
EPS
US$-3,31
Shares outstanding
48,89 ລ້ານ
No. of employees
115
Open
US$6,84
High
US$7,14
Low
US$6,77
Mkt. cap
342,72 ລ້ານ
Avg. vol.
454,25 ພັນ
Volume
95,99 ພັນ
52-wk high
US$14,53
52-wk low
US$2,71
EPS
US$-3,31
Shares outstanding
48,89 ລ້ານ
No. of employees
115
News stories
From web sources and news partners
About Artiva Biotherapeutics Inc
CEO-
Employees115
Founded2019
Headquarters-
SectorBiotechnology
Websiteartivabio.com
Analyst ratings
Based on 3 analysts giving stock ratings to ARTV in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ARTV in the last 3 months.
Highest
Current US$7,01
US$41,00 (+484,88%)
Average
US$38,00 (+442,08%)
Lowest
US$35,00 (+399,29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Gil Blum
Needham
Buy
Maintained
US$41,00
+484,9%
10/01/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
US$35,00
+399,3%
10/01/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
US$40,00
+470,6%
05/25/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$23,00
+228,1%
05/21/2026
Martin Fan
Wedbush
Buy
Maintained
US$40,00
+470,6%
05/21/2026
David Nierengarten
Wedbush
Buy
Maintained
US$40,00
+470,6%
05/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
17,63 ລ້ານ
16,99 ລ້ານ
19,31 ລ້ານ
21,92 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,26 ລ້ານ
4,94 ລ້ານ
5,12 ລ້ານ
4,96 ລ້ານ
Operating expense
22,90 ລ້ານ
21,93 ລ້ານ
24,43 ລ້ານ
26,89 ລ້ານ
Total operating expenses
22,90 ລ້ານ
21,93 ລ້ານ
24,43 ລ້ານ
26,89 ລ້ານ
Operating income
-22,90 ລ້ານ
-21,93 ລ້ານ
-24,43 ລ້ານ
-26,89 ລ້ານ
Other non operating income
-3,00 ພັນ
-1,88 ລ້ານ
2,00 ພັນ
-1,00 ພັນ
EBT including unusual items
-21,53 ລ້ານ
-20,77 ລ້ານ
-23,52 ລ້ານ
-25,00 ລ້ານ
EBT excluding unusual items
-21,53 ລ້ານ
-22,65 ລ້ານ
-23,52 ລ້ານ
-25,00 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-21,53 ລ້ານ
-20,77 ລ້ານ
-23,52 ລ້ານ
-25,00 ລ້ານ
Net profit margin
-
-
-
-
Earnings per share
-0,88
-0,84
-0,95
-0,63
Interest and investment income
1,37 ລ້ານ
1,16 ລ້ານ
912,00 ພັນ
1,89 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
1,37 ລ້ານ
1,16 ລ້ານ
912,00 ພັນ
1,89 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-22,24 ລ້ານ
-21,27 ລ້ານ
-23,76 ລ້ານ
-26,20 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google